Literature DB >> 33456712

Total lesion glycolysis in oral squamous cell carcinoma as a biomarker derived from pre-operative FDG PET/CT outperforms established prognostic factors in a newly developed multivariate prediction model.

Gerrit Spanier1, Daniela Weidt2, Dirk Hellwig2, Johannes K H Meier1, Torsten E Reichert1, Jirka Grosse2.   

Abstract

PURPOSE: Retrospective study to investigate the impact of image derived biomarkers from [18F]FDG PET/CT prior to surgical resection in patients with initial diagnosis of oral squamous cell carcinoma (OSCC), namely SUVmax, SUVmean, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) of the primary tumor to predict overall survival (OS).
MATERIALS AND METHODS: 127 subsequent patients with biopsy-proven OSCC were included who underwent [18F]FDG PET/CT before surgery. SUVmax, SUVmean, MTV and TLG of the primary tumor were measured. OS was estimated according to Kaplan-Meier and compared between median-splitted groups by the log-rank test. Prognostic parameters were analyzed by uni-/multivariate Cox-regression.
RESULTS: During follow-up 52 (41%) of the patients died. Median OS was longer for patients with lower MTV or lower TLG. SUVmax and SUVmean failed to be significant predictors for OS. Univariate Cox-regression identified MTV, TLG, lymph node status and UICC stage as prognostic factors. By multivariate Cox-regression MTV and TLG turned out to be independent prognostic factors for OS.
CONCLUSIONS: The pre-therapeutic [18F]FDG PET/CT parameters MTV and TLG in the primary tumor are prognostic for OS of patients with an initial diagnosis of OSCC. TLG is the strongest independent prognostic factor for OS and outperforms established prognostic parameters in OSCC. Copyright:
© 2021 Spanier et al.

Entities:  

Keywords:  FDG PET/CT; MTV; TLG; oral squamous cell carcinoma; prognostic value

Year:  2021        PMID: 33456712      PMCID: PMC7800778          DOI: 10.18632/oncotarget.27857

Source DB:  PubMed          Journal:  Oncotarget        ISSN: 1949-2553


  62 in total

1.  Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.

Authors:  Kristin A Higgins; Jenny K Hoang; Michael C Roach; Junzo Chino; David S Yoo; Timothy G Turkington; David M Brizel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-27       Impact factor: 7.038

2.  Validation of metabolic tumor volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery.

Authors:  Han Zhang; Hadi Seikaly; Nhu-Tram Nguyen; Jonathan T Abele; Peter T Dziegielewski; Jeffrey R Harris; Daniel A O'Connell
Journal:  Oral Oncol       Date:  2016-03-31       Impact factor: 5.337

3.  Use of pretreatment metabolic tumor volumes on PET-CT to predict the survival of patients with squamous cell carcinoma of esophagus treated by curative surgery.

Authors:  Weng-Yoon Shum; Hueisch-Jy Ding; Ji-An Liang; Kuo-Yang Yen; Shang-Wen Chen; Chia-Hung Kao
Journal:  Anticancer Res       Date:  2012-09       Impact factor: 2.480

Review 4.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

5.  Pretreatment (18)F-FDG PET/CT in whole-body total lesion glycolysis to predict survival in patients with pharyngeal cancer treated with definitive radiotherapy.

Authors:  Shang-Wen Chen; Te-Chun Hsieh; Kuo-Yang Yen; Ji-An Liang; Chia-Hung Kao
Journal:  Clin Nucl Med       Date:  2014-05       Impact factor: 7.794

6.  Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen.

Authors:  Jean-François Daisne; Thierry Duprez; Birgit Weynand; Max Lonneux; Marc Hamoir; Hervé Reychler; Vincent Grégoire
Journal:  Radiology       Date:  2004-08-18       Impact factor: 11.105

7.  Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity.

Authors:  In Sun Ryu; Jae Seung Kim; Jong-Lyel Roh; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-01       Impact factor: 9.236

Review 8.  Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview.

Authors:  Laura Evangelista; Anna Rita Cervino; Sotirios Chondrogiannis; Maria Cristina Marzola; Anna Margherita Maffione; Patrick M Colletti; Pier Carlo Muzzio; Domenico Rubello
Journal:  Nucl Med Commun       Date:  2014-02       Impact factor: 1.690

9.  Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

Authors:  Robert L Ferris; George Blumenschein; Jerome Fayette; Joel Guigay; A Dimitrios Colevas; Lisa Licitra; Kevin Harrington; Stefan Kasper; Everett E Vokes; Caroline Even; Francis Worden; Nabil F Saba; Lara C Iglesias Docampo; Robert Haddad; Tamara Rordorf; Naomi Kiyota; Makoto Tahara; Manish Monga; Mark Lynch; William J Geese; Justin Kopit; James W Shaw; Maura L Gillison
Journal:  N Engl J Med       Date:  2016-10-08       Impact factor: 91.245

10.  Metabolic Tumour Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma.

Authors:  Jasmin Mettler; Horst Müller; Conrad-Amadeus Voltin; Christian Baues; Bernd Klaeser; Alden Moccia; Peter Borchmann; Andreas Engert; Georg Kuhnert; Alexander E Drzezga; Markus Dietlein; Carsten Kobe
Journal:  J Nucl Med       Date:  2018-06-07       Impact factor: 10.057

View more
  3 in total

1.  Salivary Metabolomics for Prognosis of Oral Squamous Cell Carcinoma.

Authors:  Shigeo Ishikawa; Masahiro Sugimoto; Tsuneo Konta; Kenichiro Kitabatake; Shohei Ueda; Kaoru Edamatsu; Naoki Okuyama; Kazuyuki Yusa; Mitsuyoshi Iino
Journal:  Front Oncol       Date:  2022-01-05       Impact factor: 6.244

Review 2.  Advances in Image-Guided Radiotherapy in the Treatment of Oral Cavity Cancer.

Authors:  Hsin-Hua Nien; Li-Ying Wang; Li-Jen Liao; Ping-Yi Lin; Chia-Yun Wu; Pei-Wei Shueng; Chen-Shuan Chung; Wu-Chia Lo; Shih-Chiang Lin; Chen-Hsi Hsieh
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

3.  Implications of Standardized Uptake Values of Oral Squamous Cell Carcinoma in PET-CT on Prognosis, Tumor Characteristics and Mitochondrial DNA Heteroplasmy.

Authors:  Lukas Latzko; Bernd Schöpf; Hansi Weissensteiner; Federica Fazzini; Liane Fendt; Eberhard Steiner; Emanuel Bruckmoser; Georg Schäfer; Roy-Cesar Moncayo; Helmut Klocker; Johannes Laimer
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.